New clues to why aggressive prostate cancer subtype can resist treatment
Australian research has identified a new mechanism in which prostate cancer cells can ‘switch’ character…
Browsing: miR-194
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- Protected: Tecentriq® (atezolizumab) and Avastin® (bevacizumab) combination now reimbursed for Australians living with the most common form of liver cancer
- Victorians continue to access compassionate VAD options
- Researchers illuminate potential precursors of blood cancers
- Attending consecutive mammography screens protects against breast cancer death
- Ambulatory function among cancer survivors: important determinant for survival
- Women in Global Oncology: Rachel Riechelmann
- Collagen plays protective role during pancreatic cancer development
- The OJC Episode 26: IASLC World Conference on Lung Cancer Part 2
